{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:53:33Z","timestamp":1770141213128,"version":"3.49.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>The Epstein\u2013Barr virus (EBV) is implicated in several lymphoproliferative disorders, particularly among children and adolescents who frequently experience primary EBV infection. MicroRNA-155 (miR-155), an oncogenic and immunoregulatory molecule, is known to participate in EBV-related immune modulation; however, its expression profile and relationship with EBV serological markers and inflammatory cytokines in young lymphoma patients remain insufficiently characterized. This cross-sectional observational study included 80 participants, comprising 40 young lymphoma patients with serological evidence of active EBV infection and 40 healthy controls. Serum EBV IgM and IgG levels were measured using ELISA, as were IL-18 and IL-32 concentrations, while serum miR-155 levels were quantified using qRT-PCR with an absolute quantification approach. The mean age of participants was 13.19 \u00b1 2.51 years, and 55% were male. Serum miR-155 levels were significantly higher in lymphoma patients compared with controls (median: 1.13 vs. 0.43\u00a0ng\/mL; p = 0.012). Elevated miR-155 expression was significantly associated with EBV IgM positivity (p &amp;lt; 0.001), IL-18 (p = 0.001), and IL-32 (p &amp;lt; 0.001). In multivariate logistic regression analysis, IL-32 positivity emerged as a strong independent predictor of elevated miR-155 levels (AOR = 19.02, p = 0.001). Receiver operating characteristic curve analysis demonstrated good discriminative performance of miR-155 (AUC = 0.87), with 87% sensitivity and 90% specificity at a cutoff value of \u22651.11\u00a0ng\/mL. These findings indicate that serum miR-155 is significantly elevated in young lymphoma patients with serological evidence of active EBV infection and is statistically associated with inflammatory cytokines, particularly IL-32. miR-155 may represent a promising non-invasive biomarker reflecting EBV-related immune activation, although tissue-based EBV confirmation and mechanistic studies are required to establish causality.<\/jats:p>","DOI":"10.3389\/ebm.2026.10869","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:10:09Z","timestamp":1770099009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of MicroRNA-155 and its associations with EBV serological markers and inflammatory cytokines in young lymphoma patients with evidence of active EBV infection"],"prefix":"10.3389","volume":"251","author":[{"given":"Lezan Medhat","family":"Mohammed","sequence":"first","affiliation":[{"name":"Medical Technical Institute\/Kirkuk, Northern Technical University, Ministry of Higher Education and Scientific Research","place":["Kirkuk, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payman S.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Nurse, Medical Technical Institute\/Kirkuk, Northern Technical University, Ministry of Higher Education and Scientific Research","place":["Kirkuk, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Qasim","family":"Taha","sequence":"additional","affiliation":[{"name":"Department of Nurse, Medical Technical Institute\/Kirkuk, Northern Technical University, Ministry of Higher Education and Scientific Research","place":["Kirkuk, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luay M.","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Public Health, Kirkuk Health Directorate, Iraqi Ministry of Health (MOH)","place":["Kirkuk, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.3390\/cancers16244212","article-title":"The functional interaction between epstein-barr virus and MYC in the pathogenesis of burkitt lymphoma","volume":"16","author":"Solares","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.19255","article-title":"Epstein-barr virus-associated lymphomas decoded","volume":"204","author":"Bednarska","year":"2024","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.56286\/ntujps.v2i4","article-title":"Prevalence of epstein-barr virus among hemodialysis patients in Kirkuk city","volume":"2","author":"Ihsan","year":"2023","journal-title":"NTU J Pure Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.4103\/mjbl.mjbl_780_23","article-title":"Correlation of interleukin-10 and interleukin-8 with cytomegalovirus","volume":"21","author":"Ihsan","year":"2024","journal-title":"Med J Babylon"},{"key":"B5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12985-023-02187-9","article-title":"Epstein-barr virus infection: the micro and macro worlds","volume":"20","author":"Huang","year":"2023","journal-title":"Virol J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/microorganisms11102606","article-title":"Detection and quantification of the epstein-barr virus in lymphoma patients from Ethiopia: molecular and serological approaches","volume":"11","author":"Teshome","year":"2023","journal-title":"Microorganisms"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/biomedicines12122658","article-title":"The role of microRNA-155 as a biomarker in diffuse large B-Cell lymphoma","volume":"12","author":"Koumpis","year":"2024","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e157248","DOI":"10.1172\/JCI157248","article-title":"Breast cancer cell-derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function","volume":"132","author":"Wang","year":"2022","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e00716","DOI":"10.1128\/JVI.00716-18","article-title":"Enhancer control of MicroRNA miR-155 expression in epstein-barr virus-infected B cells","volume":"92","author":"Wood","year":"2018","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","article-title":"MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis","volume":"108","author":"Kurowska-Stolarska","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/cancers17091481","article-title":"Epstein-barr infection, hodgkin's lymphoma, and the immune System: insights into the molecular mechanisms facilitating immune evasion","volume":"17","author":"Tsotridou","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13365-017-0574-4","article-title":"Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus","volume":"23","author":"Zalinger","year":"2017","journal-title":"J Neurovirol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967-022-03375-x","article-title":"IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1\/microRNA-155 axis","volume":"20","author":"Chang","year":"2022","journal-title":"J Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/ijerph16040524","article-title":"Age-related differences in miRNA expression in Mexican-American newborns and children","volume":"16","author":"Huen","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3389\/fimmu.2016.00615","article-title":"Comparison of the functional microRNA expression in immune cell subsets of neonates and adults","volume":"7","author":"Yu","year":"2016","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","article-title":"Regulation of microRNA expression and abundance during lymphopoiesis","volume":"32","author":"Kuchen","year":"2010","journal-title":"Immunity"},{"key":"B17","article-title":"Sample size determination in health studies: a practical manual. Geneva, Switzerland: World Health Organization","author":"Lwanga","year":"1992"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cancergencyto.2007.10.008","article-title":"Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma","volume":"181","author":"Rai","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"B20","article-title":"Human Epstein-barr virus IgG (EBv-IgG) ELISA kit","year":"2025","journal-title":"MyBioSource,"},{"key":"B21","unstructured":"Human IL-18(Interleukin 18) ELISA kit (E-EL-H0253). Elabscience Biotechnology Co., Ltd., Wuhan, Hubei, China\n          \n          \n          2025"},{"key":"B22","unstructured":"Human IL-32(Interleukin 32) ELISA kit (E-EL-H0216). Elabscience Biotechnology Co., Ltd., Wuhan, Hubei, China\n          \n          \n          2025"},{"key":"B23","volume-title":"miRNeasy kit for miRNA purification","year":"2025"},{"key":"B24","volume-title":"Reverse transcription","year":"2025"},{"key":"B25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2217\/fvl-2018-0120","article-title":"The epstein-barr virus LMP1 interactome: biological implications and therapeutic targets","volume":"13","author":"Cheerathodi","year":"2018","journal-title":"Future Virol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/ijms25158160","article-title":"Epstein-barr viruses: their immune evasion strategies and implications for autoimmune diseases","volume":"25","author":"Zhao","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/ol.2023.14187","article-title":"Role of interleukin-32 in cancer progression","volume":"27","author":"Meng","year":"2023","journal-title":"Oncol Lett"},{"key":"B29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.immuni.2004.12.003","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2042-6410-5-3","article-title":"Influence of sex differences on microRNA gene regulation in disease","volume":"5","author":"Sharma","year":"2014","journal-title":"Biol Sex Differ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","article-title":"microRNA profiling in epstein-barr virus-associated B-cell lymphoma","volume":"39","author":"Imig","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2026.10869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:10:10Z","timestamp":1770099010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2026.10869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":31,"alternative-id":["10.3389\/ebm.2026.10869"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2026.10869","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"10869"}}